Patents by Inventor Ulrike Hahn

Ulrike Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS
    Publication number: 20230159581
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Application
    Filed: July 26, 2022
    Publication date: May 25, 2023
    Applicant: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • Anti-infective and anti-inflammatory compounds
    Patent number: 11420995
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: August 23, 2022
    Assignee: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • NOVEL ANTI-INFECTIVE AND ANTI-INFLAMMATORY COMPOUNDS
    Publication number: 20200262857
    Abstract: Lysosomally accumulated substances that release a nitroxy group, or a short chain fatty acid or a product of anaerobic metabolism or a thiol or a sulfide often from an ester or similar labile linkage have anti-inflammatory, anti-cancer and anti-bacterial activity. They are useful in treating infectious, inflammatory and malignant disease.
    Type: Application
    Filed: March 2, 2018
    Publication date: August 20, 2020
    Applicant: Synovo GmbH
    Inventors: Nikolas Pietrzik, Michael W. Burnet, Christiane Baeuerlein, Mary Eggers, Jan-Hinrich Guse, Ulrike Hahn, Simon Strass
  • KINASE MODULATORS FOR THE TREATMENT OF CANCER
    Publication number: 20170313661
    Abstract: A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when given in combination with, or in the presence of TNFa. Said method is effective when provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.
    Type: Application
    Filed: April 10, 2017
    Publication date: November 2, 2017
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Ulrike Hahn
  • Kinase modulators for the treatment of cancer
    Patent number: 9617221
    Abstract: A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when given in combination with, or in the presence of TNFa. Said method is effective when provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.
    Type: Grant
    Filed: August 15, 2012
    Date of Patent: April 11, 2017
    Assignee: Synovo GmbH
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Ulrike Hahn
  • KINASE MODULATORS FOR THE TREATMENT OF CANCER
    Publication number: 20130045938
    Abstract: A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when given in combination with, or in the presence of TNFa. Said method is effective when provided in addition to standard therapies, notably chemotherapy using cytotoxic drugs and other forms of immune therapy including therapeutic vaccines.
    Type: Application
    Filed: August 15, 2012
    Publication date: February 21, 2013
    Applicant: Synovo GmbH
    Inventors: Michael W. Burnet, Jan-Hinrich Guse, Christiane Bauerlein, Ulrike Hahn
  • Method for Examining the Activity of Ion Channels
    Publication number: 20070281330
    Abstract: The present invention relates to a method for examining the activity of ion channels, comprising the following steps: providing a sample comprising ion channels; and determining a value of a measuring parameter as an indicator of the activity of the ion channels; characterized in that said determining of the value of the measuring parameter is performed at a temperature of ? about 10° C.
    Type: Application
    Filed: January 14, 2005
    Publication date: December 6, 2007
    Inventors: Andreas Ebneth, Rainer Netzer, Ulrike Hahn